Trial
NCT02661100
A Trial of CDX-1401 in Combination With Poly-ICLC and Pembrolizumab, in Previously Treated Advanced Solid Tumor Patients
Phase IWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
Case Comprehensive Cancer Center
Collaborators
—
Condition
Non Small Cell Lung Cancer
Intervention
Pembrolizumab
Why stopped
Drug unavailable
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2016-12-07